Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Insulin Pricing topic
No spam. Unsubscribe anytime.
Highlands County School Board authorizes joining insulin‑pricing multidistrict litigation
Summary
After an outside counsel presentation, the Highlands County School Board voted to authorize retaining contingency‑fee lawyers to pursue claims in a federal multi‑district litigation that alleges insulin manufacturers and PBMs overcharged government purchasers.
The Highlands County School Board voted to authorize the retention of outside counsel to pursue claims related to insulin pricing in pending multi‑district litigation. The board acted after a presentation by Natalia Salas, a partner at the Ferraro Law Firm, who described consolidated federal cases alleging price‑fixing and a lack of transparency by insulin manufacturers and pharmacy benefit managers (PBMs).
Salas told the board the firm represents government entities on contingency and has been appointed to leadership in part of the MDL. She said the litigation aims to recoup amounts that self‑funded payers — including some school districts — paid for insulin and insulin analogs, and estimated a conservative overpayment figure of roughly $5,000 per insulin user per year going back to 2001. Salas said about 50 government entities and clients in roughly 14 states had signed on or filed to date and urged enrollment before a statute‑of‑limitations window she said could turn in January 2025. “These cases were consolidated and sent to Judge Martinotti in the District of New Jersey,” Salas said, arguing there is an avenue for punitive and treble damages under the theory the firm is pursuing.
Board members asked no substantive follow‑up questions during the meeting and then moved to authorize the recommendation to retain outside counsel. The board’s motion to approve was seconded and carried by roll‑call vote.
The authorization directs district staff to proceed with retaining counsel for possible claims on the board’s behalf; the motion did not itself file suit or obligate the district to pay upfront legal fees, consistent with the contingency arrangement described by counsel. The presentation materials referenced a Senate Finance Committee report from 2021 that the presenter said uncovered underlying conduct at issue in the cases.
What happens next: outside counsel will review the district’s insulin spend and relevant PBM contracts and, if the board desires, move forward with filing or joining claims in the MDL. The board’s approval at the meeting authorized that retention; no damages award or settlement was announced at the meeting.
